The role of butyric acid as a protective agent against inflammatory bowel diseases

EuroMediterranean Biomedical Journal

Volumn 9, Issue , 2014, Pages 24-35

  Tralongo, Pietro ^a   Tomasello, Giovanni ^a,b   Sinagra, Emanuele ^a,c   Damiani, Provvidenza ^a,d   Leone, Angelo ^a   Palumbo, Vincenzo Davide ^a   Giammanco, Marco ^a   Di Majo, Danila ^a   Damiani, Francesco ^a   Abruzzo, Alida ^a   Bruno, Antonio ^a   Cassata, Giovanni ^e   Cicero, Luca ^e   Noto, Marcello ^a   Tomasello, Riccardo ^a   Lo Monte, Attilio Ignazio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Euro Mediterranean Institute of Science and Technology   (Italy)

^c Fondazione Istituto S Raffaele G Giglio Gastroenterology and Endoscopy Unit   (Italy)

^d Medical Resident in Geriatrics   (Italy)

^e ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA SICILIA A MIRRI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84894381926     PISSN: 22797165     EISSN: None     Source Type: Journal    
DOI: 10.3269/1970-5492.2014.9.4     Document Type: Review

References (55)

1. Margiotta G, Sanfilippo A, Accardo F M, Damiani P, Geraci A, Tomasello G: Chronic inflammatory bowel diseases in patients with orthopedic manifestation. Comparison with the data reported in international literature. Euromediterranean Biomedical Journal 2012; 7(7):33-38.
2. Geraci A, Tomasello G, Sabetta S P: Or-thopaedic Experience on Inflammatory Bowel Disease (Lesniowski-Crohn's Disease and Ulcerative Colitis). Ortop Traumatol Rehabil. 2010; 12(5):430-434.
3. Ouyang, Q, Tandon, R, Goh, K. L., Ooi, C. J., Ogata, H. & Fiocchi, C.: The emer-gence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastro-enterol. 2005; 21(4):408-413.
4. Danese S & Fiocchi C: Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol 2006; 12(30): 4807-4812.
5. Hedin C, Whelan K & Lindsay J O: Evi-dence for the use of probiotics and pre-biotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc 2007; 66 (3): 307-315.
6. Tomasello G, Bellavia M, Damiano G, Gioviale M C and Lo Monte A I: Possible relation between gut microflora composi-tion and oncogenic risk: is stimulation of inflammation the one ring of connection? Reviews in Medical Microbiology 2012; 23:52-57
7. Javier Rivera Guzman, Victoria Susan Conlin, and Christian Jobin: Diet, Micro-biome, and the Intestinal Epithelium: An Essential Triumvirate? Biomed Res Int. 2013; 2013:425146
8. Yu L C, Wang J T, Wei S C, Ni Y H: Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. World J Gastro-intest Pathophysiol. 2012; 3(1):27-43.
9. Walsh S V, Hopkins A M, Nusrat A: Modulation of tight junction structure and function by cytokines. Adv Drug Deliv Rev. 2000; 41(3):303-313.
10. Bettelheim K A, Faiers B A, Mary C, O'Farrell S M, Sheila M, Shooter, R A: The origin of O serotypes of Escherichia coli in babies after normal delivery. Journal of Hygiene 2009; 72 (1): 67-70.
11. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linne-berg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J; MetaHIT Consor-tium, Bork P, Ehrlich SD, Wang J: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464(7285):59-65.
12. Fujimura K E, Slusher N A, Cabana M D, Lynch S V: Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther. 2010; 8(4):435-454.
13. Manichanh C, Borruel N, Casellas F & Guarner F: The gut microbiota in IBD. Na-ture Reviews Gastroenterology & Hepatol-ogy 2012; 9:599-608
14. Larsen N, Vogensen F K, Van Den Berg F W, Nielsen D S, Andreasen A S, Pedersen B K, Al-Soud W A, Sørensen S J, Hansen L H, Jakobsen M: Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010. 5(2):e9085.
15. Khachatryan Z A, Ktsoyan Z A, Manukyan G P, Kelly D, Ghazaryan K A & Aminov R I: Predominant role of host ge-netics in controlling the composition of gut microbiota. PLoS One 2008; 3(8): e3064.
16. Aurelia P, Capurso L, Castellazzi A M, Clerici M, Giovannini M, Morelli L, Poli A, Pregliasco F, Salvini F, Zuccotti G V: Probi-otics and health: An evidence-based re-view. Pharmacological Research 2011; 63: 366-376
17. Neish A S, Gewirtz A T, Zeng H, Young A N, Hobert M E, Karmali V, Rao A S, Madara J L: Prokaryotic regulation of epithelial responses by inhibition of Ikap-paB-alpha ubiquitination. Science 2000; 289:1560-1563.
18. Trask OJ: Nuclear Factor Kappa B (NF-κB) Translocation Assay Development and Validation for High Content Screening. In: Sittampalam GS, Gal-Edd N, Arkin M, Auld D, Austin C, Bejcek B, Glicksman M, Inglese J, Lemmon V, Li Z, McGee J, McManus O, Minor L, Napper A, Riss T, Trask OJ, Weidner J, editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Com-pany and the National Center for Advanc-ing Translational Sciences; 2004-2012 Oct 01.
19. Petrof E O, Claud E C, Sun J, Abramova T, Guo Y, Waypa T S, He S M, Nakagawa Y, Chang E B: Bacteria-free solution derived from Lactobacillus plantarum inhibits mul-tiple NF-kappaB pathways and inhibits proteasome function. Inflamm Bowel Dis 2009; 15 (10):1537-1547.
20. Dubuquoy L, Jansson E A, Deeb S, Ra-kotobe S, Karoui M, Colombel J F, Auwerx J, Pettersson S, Desreumaux P: Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 2003; 124(5):1265-1276.
21. Cummings J H, Macfarlane G T: The control and consequence of bacterial fer-mentation in human colon. J Appl Bacteriol 1991; 70(6):443-459
22. Hijova E, Chmelarova A: Short chain fatty acids and colonic health. Bratisl Lek Listy 2007; 108(8): 354-358
23. Cook S I, Sellin JH: short chain fatty acids in health and disease. Aliment Phar-macol Ther 1998; 12(6): 499-507
24. Roy C C, Kien C L, Bouthillier L, Levy E: Short-chain fatty acids: Ready for prime time? Nutr Clin Pract 2006; 21(4):351-366.
25. Ritzhaupt A, Ellis A, Hosie K B, Shirazi-Beechey S P: The characterization of bu-tyrate transport across pig and human colonic luminal membrane. J Physiol 1998; 507(Pt3): 819-830.
26. Ganapathy V, Thangaraju M, Gopal E, Martin P M, Itagaki S, Miyauchi S, Prasad P D: Sodium-coupled monocarboxylate trans-porters in normal tissues and in cancer. AAPS J 2008; 10:193-199.
27. Donohoe D R, Garge N, Zhang X, Sun W, O'Connell T M, Bunger M K and Bultman S J: The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon. Cell Metab. 2011; 13(5): 517-526
28. Duncan S H, Louis P, Thomson J M, Flint H J: The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol. 2009; 11(8):2112-2122.
29. Sokol H, Pigneur B, Watterlot L, Lakh-dari O, Bermudez-Humaran L G, Gratadoux J J, Blugeon S, Bridonneau C, Furet J P Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière H M, Doré J, Marteau P, Seksik P, Langella P: Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identi-fied by gutmicrobiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008; 105(43):16731-16736
30. Takaishi H, Matsuki T, Nakazawa A, Takada T, Kado S, Asahara T, Kamada N, Sakuraba A, Yajima T, Higuchi H, Inoue N, Ogata H, Iwao Y, Nomoto K, Tanaka R, Hibi T: Imbalance in intestinal microflora con-stitution could be involved in the patho-genesis of inflammatory bowel disease. Int J Med Microbiol. 2008; 298(5-6):463-472
31. Van Immerseel F, Ducatelle R, De Vos M, Boon N, Van De Wiele T, Verbeke K, Rutgeerts P, Sas B, Louis P, Flint H J: Bu-tyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. J Med Micro-biol. 2010; 59(Pt 2):141-143
32. Venkatraman A, Ramakrishna B S, R. Shaji V, Nanda Kumar N S, Pulimood A, Patra S: Amelioration of dextran sulfate colitis by butyrate: role of heat shock pro-tein 70 and NF-κB. Am J Physiol Gastro-intest Liver Physiol. 2003; 285(1):G177-184
33. Breuer R I, Soergel K H, Lashner B A, Christ M L, Hanauer S B, Vanagunas A, Harig J M, Keshavarzian A, Robinson M, Sellin J H, Weinberg D, Vidican D E, Flemal K L, Rademaker A W: Short-chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomized, placebo-controlled trial. Gut 1997; 40 (4):485-491.
34. Duncan S H, Belenguer A, Holtrop G, Johnstone A M, Flint H J, Lobley GE: Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol. 2007; 73(4):1073-1078.
35. Chapman M A, Grahn M F, Hutton M, Williams N S: Butyrate metabolism in the terminal ileal mucosa of patients with ulcerative colitis. Br J Surg. 1995; 82(1):36-38.
36. Segain J P, Raingeard de la Blétière D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottière H M, Galmiche J P: Butyrate inhibits inflammatory re-sponses through NFkappaB inhibition: implications for Crohn's disease. Gut. 2000; 47(3):397-403
37. Lewis K, Lutgendorff F, Phan V, Söder-holm J D, Sherman P M, McKay D M: Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis. 2010; 16(7):1138-1148.
38. Plöger S, Stumpff F, Penner GB, Schul-zke JD, Gäbel G, Martens H, Shen Z, Günzel D, Aschenbach JR: Microbial butyrate and its role for barrier function in the gastroin-testinal tract. Ann N Y Acad Sci. 2012;1258:52-59.
39. Macario A J, Lange M, Ahring B K, Conway de Macario E: Stress genes and proteins in the archaea. Microbiol Mol Biol Rev. 1999; 63(4):923-967
40. Prohászka Z, Füst G. Immunological aspects of heat-shock proteins-the opti-mum stress of life. Mol Immunol 2004; 41: 29-44.
41. Cappello F, Conway de Macario E, Di Felice V, Zummo G, Macario A J. Chlamydia trachomatis infection and anti-Hsp60 im-munity: the two sides of the coin. PLoS Pathog. 2009; 5(8):e1000552.
42. Otaka M, Odashima M, Watanabe S: Role of heat shock proteins (molecular chaperones) in intestinal mucosal protec-tion. Biochem Biophys Res Commun 2006; 348(1):1-5.
43. Bellavia M, Tomasello G, Romeo M, Damiani P, Lo Monte A I, Lozio L, Campan-ella C, Gammazza A M, Rappa F, Zummo G, Cocchi M, Conway de Macario E, Macario AJ, Cappello F: Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis. Med Microbiol Immunol. 2013; 202(6):393-406
44. Imamura Y, Kurokawa M S, Yoshikawa H, Nara K, Takada E, Masuda C, Tsukikawa S, Ozaki S, Matsuda T, Suzuki N: Involve-ment of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol 2005; 139(2):371-378
45. Pockley A G, Muthana M and Calder-wood S K: The dual immunoregulatory roles of stress proteins. Trends Biochem Sci 2008; 33(2):71-79
46. Corrao S, Campanella C, Anzalone R, Farina F, Zummo G, Conway de Macario E, Macario A J, Cappello F, La Rocca G: Hu-man Hsp10 and Early Pregnancy Factor (EPF) and their relationship and involve-ment in cancer and immunity: current knowledge and perspectives. Life Sci 2010; 86(5-6):145-152
47. Tomasello G, Rodolico V, Zerilli M, Martorana A, Bucchieri F, Pitruzzella A, Marino Gammazza A, David S, Rappa F, Zummo G, Damiani P, Accomando S, Rizzo M, de Macario EC, Macario A J, Cappello F: Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis. Appl Immuno-histochem Mol Morphol 2011; 19(6):552-561
48. Peppercorn M A, Goldman P: The role of intestinal bacteria in the metabolism of salicylazo-sulfapyridine. J Pharmacol Exp Ther. 1972; 181(3):555-562.
49. Tomasello G, Sciumé C, Rappa F, Rodolico V, Zerilli M, Martorana A, Cicero G, De Luca R, Damiani P, Accardo FM, Romeo M, Farina F, Bonaventura G, Modica G, Zummo G, Conway de Macario E, Macario A J, Cappello F: Hsp10, Hsp70, and Hsp90 immunohistochemical level change in ulcerative colitis after therapy. Eur J Histochem. 2011; 55(4):e38
50. Hamer H M, Jonkers D, Venema K, Vanhoutvin S, Troost F J & Brummer R J: Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27(2):104-119.
51. Ellis S, Killender M, Anderson RL: Heat-induced alterations in the localization of HSP72 and HSP73 as measured by indirect immunohistochemistry and immunogold electron microscopy. J Histochem Cyto-chem. 2000; 48(3):321-332.
52. Ren H, Musch M W, Kojima K, Boone D, Ma A, Chang E B.: Short-Chain Fatty Acids Induce Intestinal Epithelial Heat Shock Protein 25 Expression in Rats and IEC 18 Cells. Gastroenterology. 2001; 121(3):631-639.
53. Huot J, Houle F, Spitz DR, Landry J: Hsp27 phosphorylation mediated resis-tance against actin fragmentation and cell death induced by oxidative stress. Cancer Res 1996; 56(2):273-279.
54. Boffa L C, Lupton J R, Marianai M R, Ceppi M, Newmark H L, Scalmati A, Lipkin M: Modulation of colonic epithelial cell proliferation, histone acetylation, and lu-minal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res 1992; 52(21):5906-5912.
55. Lallemand F, Corilleau D, Sabbah M, Reduilh G, Mestger J: Direct inhibition of the expression of cyclin D1 gene by so-dium butyrate. Biochem Biophys Res Com-mun 1996; 229(1):163-169.